Blanket purchase agreement for compound chemicals
Ended Blanket Purchase Agreement Awarded Last action
- Contract number
- HT001420A0018
- Awardee
-
The Compounding Center Inc. UEI J69ERCPB7369
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 4 $305,000 obligated
Award facts
- Combined order value
- $305,000 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 5% used
- $6,500,000.00
- Maximum order
- $650,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded a blanket purchase agreement to The Compounding Center Inc. to provide various pharmaceutical supplies and compounded medications. Under four firm fixed price call contracts valued between $25,000 to $150,000 placed against the agreement, the contractor will deliver shortage pharmaceuticals, compounded drugs, and chemical compounds to Walter Reed National Military Medical Center in Bethesda, Maryland. Performance is scheduled to take place through various completion dates between March 2022 and April 2021. No set-aside provisions were applied to the awards. The Compounding Center will fulfill requirements for critical medical supplies to directly support patient care at the military treatment facility, addressing shortages and compounded medication needs. The blanket agreement and follow-on calls aim to streamline the procurement of essential pharmaceuticals for the Defense Health Agency's network of hospitals and clinics in treating military personnel and their families.
The Defense Health Agency awarded the single award blanket purchase agreement with a potential value of $6.5M to The Compounding Center on March 6, 2020, with an ordering period extending through March 5, 2025. Under the terms of the agreement and follow-on calls issued, the contractor provides specialized pharmaceuticals, supplies, and services including compounded drugs to military medical centers managed by the funding agency. Performance of the calls occurs at locations in the Bethesda, Maryland area. The awards allow for expedited acquisition of needed medications and compounds for the military health system under the Defense Health Agency's responsibility to ensure medical readiness.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Atrophine dextrose heparin hydralazine | Defense Health Agency | $65,000 | |
| Pharmaceutical supplies | Defense Health Agency | $25,000 | |
| Call order for various pharmaceuticals shortages to support walter reed. | Defense Health Agency | $65,000 | |
| Shortage pharmaceuticals for walter reed national military medical center | Defense Health Agency | $150,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HT001420A0018?
HT001420A0018 was awarded to The Compounding Center Inc. by Defense Health Agency (Department of Defense) on March 6, 2020.
How much is contract HT001420A0018 worth?
Orders under HT001420A0018 have obligated $305,000. HT001420A0018's own ceiling is $6,500,000. A single order can be worth up to $650,000.
How many orders have been placed under contract HT001420A0018?
4 orders have been placed under HT001420A0018, the latest on March 16, 2022.
Who can order from contract HT001420A0018?
HT001420A0018 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV